HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 280, Issue 32, 29322-29333, August 12, 2005

This Article Full Text Full Text (PDF) All Versions of this Article: 280/32/29322    most recent M502080200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Waxman, E. A. Articles by Lynch, D. R. Search for Related Content PubMed PubMed Citation Articles by Waxman, E. A. Articles by Lynch, D. R. Social Bookmarking                      What's this?

N-Methyl-D-aspartate Receptor Subtype Mediated Bidirectional Control of p38 Mitogen-activated Protein Kinase^*

Elisa A. Waxman and David R. Lynch¶||**

From the Departments of Pharmacology, Neurology, and ^¶Pediatrics, University of Pennsylvania School of Medicine and the ^||Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104

N-methyl-D-aspartate receptor (NMDAR) stimulation activates many downstream mechanisms involved in both cell survival and cell death. The manner in which the NMDAR regulates one of these pathways, the p38 mitogen-activated protein kinase (p38) pathway, is currently unknown. In the present study, we have defined a developmental-, concentration-, and time-dependent phosphorylation and subsequent dephosphorylation of p38. In cultured hippocampal neurons 7-8 days in vitro (DIV7-8), NMDAR stimulation leads to a concentration-dependent increase in p38 phosphorylation (phospho-p38). However, in more mature neurons (>DIV17) application of NMDA produces concentration-dependent effects, such that low concentrations result in sustained increases in phospho-p38 levels, and high concentrations dephosphorylate p38 within 5 min. Conantokin G, an antagonist of NR1/2A/2B and NR1/2B receptors, inhibits p38 phosphorylation, while NR1/2B-specific antagonists prevent the rapid dephosphorylation of p38 without affecting p38 activation. Furthermore, inhibition of calcineurin prevents the activation of p38, whereas inhibition of phosphoinositide 3-kinase (PI3K) prevents the rapid dephosphorylation of p38. Our results support the presence of subtype-dependent pathways regulating p38 activation and deactivation: one involves NR1/2A/2B receptors activating calcineurin and resulting in p38 phosphorylation, and the other utilizes NR1/2B receptors binding to and activating PI3K and leading to the dephosphorylation of p38 in a manner involving both NR1/2A/2B receptor activation and tyrosine phosphorylation of NR2B. The ability of NMDAR subtype-specific mechanisms to regulate p38 has implications for NMDAR-mediated synaptic plasticity, gene regulation, and excitotoxicity.

Received for publication, February 23, 2005 , and in revised form, June 1, 2005.

^* This work was supported by National Institutes of Health Grants NS45986 (to D. R. L.), and T32 MH 14654 (to E. A. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

^** To whom correspondence should be addressed: 502 Abramson Bldg., Children's Hospital of Philadelphia, 3615 Civic Center Blvd., Philadelphia, PA 19104. Tel.: 215-590-2242; Fax: 215-590-3779: E-mail: lynch{at}pharm.med.upenn.edu.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				F. X. Soriano, M.-A. Martel, S. Papadia, A. Vaslin, P. Baxter, C. Rickman, J. Forder, M. Tymianski, R. Duncan, M. Aarts, et al. Specific Targeting of Pro-Death NMDA Receptor Signals with Differing Reliance on the NR2B PDZ Ligand J. Neurosci., October 15, 2008; 28(42): 10696 - 10710. [Abstract] [Full Text] [PDF]

				H.-Y. Wu, F.-C. Hsu, A. J. Gleichman, I. Baconguis, D. A. Coulter, and D. R. Lynch Fyn-mediated Phosphorylation of NR2B Tyr-1336 Controls Calpain-mediated NR2B Cleavage in Neurons and Heterologous Systems J. Biol. Chem., July 13, 2007; 282(28): 20075 - 20087. [Abstract] [Full Text] [PDF]

				I. Medina Extrasynaptic NMDA Receptors Reshape Gene Ranks Sci. Signal., May 15, 2007; 2007(386): pe23 - pe23. [Abstract] [Full Text] [PDF]

				G. A. Rameau, D. S. Tukey, E. D. Garcin-Hosfield, R. F. Titcombe, C. Misra, L. Khatri, E. D. Getzoff, and E. B. Ziff Biphasic Coupling of Neuronal Nitric Oxide Synthase Phosphorylation to the NMDA Receptor Regulates AMPA Receptor Trafficking and Neuronal Cell Death J. Neurosci., March 28, 2007; 27(13): 3445 - 3455. [Abstract] [Full Text] [PDF]

				Y. Liu, T. P. Wong, M. Aarts, A. Rooyakkers, L. Liu, T. W. Lai, D. C. Wu, J. Lu, M. Tymianski, A. M. Craig, et al. NMDA Receptor Subunits Have Differential Roles in Mediating Excitotoxic Neuronal Death Both In Vitro and In Vivo J. Neurosci., March 14, 2007; 27(11): 2846 - 2857. [Abstract] [Full Text] [PDF]

				A. B. Alex, A. J. Baucum, and K. S. Wilcox Effect of Conantokin G on NMDA Receptor-Mediated Spontaneous EPSCs in Cultured Cortical Neurons J Neurophysiol, September 1, 2006; 96(3): 1084 - 1092. [Abstract] [Full Text] [PDF]